EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

A delayed sequential treatment protocol provides effective neuroprotection for sarin-induced status epilepticus in rats

Shlomi Lazar, Adi Neufeld-Cohen, Inbal Egoz, Shlomi Baranes, Rellie Gez, Pnina Glick, Maayan Cohen, Hila Gutman, Shira Chapman, Dror Kraus, Ariel Gore

Pharmaceutics and Pharmacology · 2026

DOI: 10.1093/pp/rqag007 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Pharmaceutics and Pharmacology, 2026. Verfasst von Shlomi Lazar und 10 weiteren Autor:innen. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Status epilepticus (SE) following sarin exposure represents a critical therapeutic challenge, as delayed treatment with benzodiazepines often fails to prevent prolonged seizures and subsequent brain injury. This study evaluated a delayed treatment protocol combining ketamine (K) and midazolam (M), followed by the sequential administration of either valproate or levetiracetam (LEV), in reducing electrographic seizure activity (ESA), mortality, and long-term neuropathology in a rat model of sarin-induced SE.

Methods

SE was induced in rats by exposure to 1.2 LD5₀ sarin, followed 1 min later by atropine and TMB4 (TA) treatment to prevent cardiopulmonary arrest. Thirty minutes after exposure, K and M were administered, followed 30 min later by either valproate or LEV, simulating field treatment to hospital care. Outcomes were compared with delayed M monotherapy and a simultaneous triple-treatment regimen consisting of K, M, and valproate. ESA and mortality were monitored for 1 week. Behavioral assessments were performed 2 weeks postexposure, followed by biochemical and histopathological analyses at 5 weeks. Key findings Compared with TA treatment alone or TA combined with delayed M monotherapy, both the simultaneous and sequential triple-treatment regimens significantly reduced mortality, shortened ESA duration, and improved postexposure weight recovery. The treatments also reduced neuroinflammatory and neuronal injury markers, including prostaglandin E₂ and translocator protein. In addition, they attenuated gliosis, astrocytosis, and neuronal damage and normalized the sarin-induced increase in open-field activity.

Conclusions

Delayed sequential triple therapy effectively mitigated seizure activity, neuroinflammation, and long-term neuropathology. These findings support the preclinical development of sequential multidrug treatment strategies and warrant to evaluate their translational potential.

Zitieren

APA

Lazar, S., Neufeld-Cohen, A., Egoz, I., Baranes, S., Gez, R., Glick, P., Cohen, M., Gutman, H., Chapman, S., Kraus, D., & Gore, A. (2026). A delayed sequential treatment protocol provides effective neuroprotection for sarin-induced status epilepticus in rats. Pharmaceutics and Pharmacology. https://doi.org/10.1093/pp/rqag007

Vancouver

Lazar S, Neufeld-Cohen A, Egoz I, Baranes S, Gez R, Glick P, et al. A delayed sequential treatment protocol provides effective neuroprotection for sarin-induced status epilepticus in rats. Pharmaceutics and Pharmacology. 2026. doi:10.1093/pp/rqag007

BibTeX
@article{Lazar2026,
  author = {Lazar, Shlomi and Neufeld-Cohen, Adi and Egoz, Inbal and Baranes, Shlomi and Gez, Rellie and Glick, Pnina and Cohen, Maayan and Gutman, Hila and Chapman, Shira and Kraus, Dror and Gore, Ariel},
  title = {A delayed sequential treatment protocol provides effective neuroprotection for sarin-induced status epilepticus in rats},
  journal = {Pharmaceutics and Pharmacology},
  year = {2026},
  doi = {10.1093/pp/rqag007}
}
Kostenlos starten →